UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations

Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD (Epidiolex(®)) has been approved by the European Medicines Agency (EMA) for the treatment of two highly-refractory childhood-onset epilepsies (Dravet and Lenno...

Descripción completa

Detalles Bibliográficos
Autores principales: Malaca, Sara, Gottardi, Massimo, Pigliasco, Federica, Barco, Sebastiano, Cafaro, Alessia, Amadori, Elisabetta, Riva, Antonella, Marcenaro, Martina, Striano, Pasquale, Cangemi, Giuliana, Pacifici, Roberta, Pichini, Simona, Busardò, Francesco Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308640/
https://www.ncbi.nlm.nih.gov/pubmed/34209666
http://dx.doi.org/10.3390/ph14070630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308640/
https://www.ncbi.nlm.nih.gov/pubmed/34209666
http://dx.doi.org/10.3390/ph14070630

Ejemplares similares